Picture of Bioatla logo

BCAB — Bioatla News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bioatla Inc reports results for the quarter ended in December - Earnings Summary

* Bioatla Inc  BCAB.OQ  reported a quarterly adjusted loss
of 63
cents​​ per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for a loss
of 70 cents per share.
    * Reported revenue was zero​; analysts expected $1.50
million. 
    * Bioatla Inc's reported EPS for the quarter was a loss
of 63
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bioatla Inc shares had fallen by 72.1% this quarter.
    * The company reported a quarterly loss of $27.54 million.
    * Wall Street's median 12-month price target for Bioatla Inc
is
$17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 24 at 10:10 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.70          -0.63          Beat
 Sep. 30 2022      -0.80          -0.69          Beat
 Jun. 30 2022      -0.69          -0.77          Missed
 Mar. 31 2022      -0.67          -0.65          Beat

Recent news on Bioatla

See all news